Tutti i video
Psoriasi: icotrokinra, una terapia orale che amplia le opzioni terapeutiche
it
Prof. Paolo Gisondi
Welcome speech
en
Prof. Carle Paul
Psoriasis 2013 - The objective of the congress
en
Prof. Carle Paul
Prof. Luigi Naldi - Opening speech
en
BMV Plaster - Case 1
en
Prof. Marie-Aleth Richard
Making the point of the Psoriasis 2013 edition
en
La psoriasi: un problema che va "oltre" la pelle
it
BMV Plaster - Case 2
en
Prof. Marie-Aleth Richard
Koebner phenomenon in psoriasis management - Part 1
en
Prof. Laurent Misery
ADIPSO - Associazione per la difesa degli Psoriasici, Mara Maccarone, Presidente
it
I nuovi farmaci per la psoriasi
it
Prof. Fabio Ayala
La psoriasi richiede una terapia personalizzata
it
Prof. Fabio Ayala
Survery on Psoriasis services available Worldwide
en
Prof. Thomas Luger
BMV Plaster - Case 3
en
Prof. Marie-Aleth Richard
Un cerotto medicato per le persone affetta da psoriasi, Mara Maccarone, Presidente
it
Changing in landscape in curing psoriasis
en
Prof. Peter van de Kerkhof
Methatrexate worldwide survey
en
Prof. Lajos Kemeny
Breaking news: an exciting time in curing psoriasis
en
Prof. Carle Paul
BMV Plaster - Case 4
en
Prof. Marie-Aleth Richard
Koebner phenomenon in psoriasis management - Part 3
en
Prof. Laurent Misery
Psoriasi moderata: puntare alla remissione completa della malattia
it
Prof. Paolo Gisondi
Clinical Results & therapeutic strategies - PIN's website
en
Prof. Luis Dubertret
Foundation René Touraine: mission & goals
en
Prof. Carle Paul
BMV Plaster improved efficacy & advantages - Part 1
en
BMV Plaster - Case 5
en
Prof. Marie-Aleth Richard
La psoriasi e le malattie associate
en
BMV Plaster - Potential indications
en
Prof. Marie-Aleth Richard
BMV Plaster improved efficacy & advantages - Part 2
en
Looking at the future: personalised medicine and psoriasis
en
Prof. Carlo Pincelli
BMV Plaster improved efficacy & advantages - Part 3
en
Application Scientific Event 2016 - The Dutch Psoriasis Group
en
Early and proper diagnosis of utmost importance
en
Dr. Lluis Puig Sanz
BMV Plaster improved efficacy & advantages - Part I
en
Prof. Marie-Aleth Richard
Voting session & Results
Psychological aspects and impairment in psoriatic patients
en
Prof. Uwe Gieler
BMV Plaster improved efficacy & advantages - Part II
en
Prof. Marie-Aleth Richard
Congresso Nazionale SIDeMaST 2022: contenuti scientifici
it
Prof. Stefano Veraldi
MCI Group - Practical points of Congress Organisation
en
IPC Foundation: mission and aims
en
Prof. Peter van de Kerkhof
Psoriaris: a two-way psychological impact
en
Prof. Uwe Gieler
Concern regarding efficacy of treatments in psoriatic patients
en
Dr. Lluis Puig Sanz
What is psoriasis
en
Prof. Carle Paul
La ricerca sulle cellule alterate che portano alla psoriasi
it
Prof. Carlo Pincelli
General practitioners should be more aware of psoriasis
en
Prof. Nejib Doss
New Opening for Psoriasis Management 2013 - Discussion
en
Moderate psoriasis: dialogue helps calibrate the treatment
en
Dr. Jennifer Cather
Discussion - The opinion of a patient, Mara Maccarone
en
Moderate psoriasis: measuring the impact on patient's QOL
en
Dr. Andreas Pinter
Psoriaris a lifelong disease
en
Prof. A.J. Kanwar
Pattern presentation of psoriasis in childhood
en
Dr. A.S. Kumar
Psoriasis a very potent disease in Indians
en
Prof. A.J. Kanwar
Curing psoriasis in poor countries
en
Prof. Nejib Doss
Anti-II-17 receptor - Antibody KHK4827 Clinical pharmacology
en